InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (6 oper.)
Historial del iniciado
DirectivoCompras declaradas
0
Ventas declaradas
6
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the detailed record of transactions filed by Hansen Gwenn, Chief Scientific Officer. Insider active across 1 company, notably Nurix Therapeutics, Inc.. Aggregated, 41 filings have been published. Split: 0 buy · 6 sells. Total volume traded: €305k. History available since 3 May 2021. The latest transaction was filed on 4 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hansen Gwenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones41 en total
1500 títulos@ 23,8684 US$0.0015% mcap8.4% de su flujoCommon StockSEC:0001817160-26-000015:0
2611 títulos@ 24,6415 US$0.0027% mcap15.0% de su flujoCommon StockSEC:0001817160-26-000015:1
4356 títulos@ 1,86 US$0.0003% mcap1.9% de su flujoCommon StockSEC:0001817160-26-000017:0
4356 títulos@ 25,00 US$0.0045% mcap25.4% de su flujoCommon StockSEC:0001817160-26-000017:1
3750 títulos0Common StockSEC:0001817160-26-000012:0
2858 títulos0Common StockSEC:0001817160-26-000012:1
3572 títulos0Common StockSEC:0001817160-26-000012:2
3847 títulos@ 23,3828 US$0.0036% mcap42.8% de su flujoCommon StockSEC:0001817160-26-000012:3
5394 títulosCommon StockSEC:0001817160-26-000010:0
2000 títulos0Common StockSEC:0001817160-26-000008:0
3750 títulos0Common StockSEC:0001817160-26-000008:1
2858 títulos0Common StockSEC:0001817160-26-000008:2
3214 títulos@ 16,6453 US$0.0021% mcap38.1% de su flujoCommon StockSEC:0001817160-26-000008:3
31.333 títulos@ 0,84 US$21.3% de su flujoCommon StockSEC:0001817160-26-000004:0
3207 títulos0Common StockSEC:0001817160-26-000002:0
3207 títulos0Common StockSEC:0001817160-25-000005:0
3207 títulos0Common StockSEC:0001549595-25-000099:0
3206 títulos0Common StockSEC:0001549595-25-000061:0
3207 títulos0Common StockSEC:0001549595-25-000022:0
3207 títulos0Common StockSEC:0001549595-24-000147:0
3207 títulos0Common StockSEC:0001549595-24-000106:0
3206 títulos0Common StockSEC:0001549595-24-000054:0
3207 títulos0Common StockSEC:0001549595-24-000008:0
3207 títulos0Common StockSEC:0001549595-23-000058:0
3207 títulos0Common StockSEC:0001209191-23-043975:0
25 de 41 declaraciones
About Hansen Gwenn
Hansen Gwenn is Chief Scientific Officer at Nurix Therapeutics, Inc. She has 33 filings in total. In the recent filings we hold, the reported sell amount is EUR 45611 and the buy amount is EUR 0, over the period from 2021-05-04 to 2026-06-25, and the modal transaction nature is option exercise.
